CVS Health (NYSE:CVS): Q2 Non-GAAP EPS of $2.64 beats by $0.72; GAAP EPS of $2.26 beats by $0.72. Revenue of $65.34B (+3.0% Y/Y) beats by $1.05B. Operating margin of 7.16% vs. consensus of 6.32%. Shares +8.86% PM.